Kelli Powell

Kelli Powell is a seasoned professional in the pharmaceutical industry, currently serving as a Rare Disease Specialist at Zevra Therapeutics since January 2024. Prior to this role, Kelli held the position of Area Business Manager at RELIEF THERAPEUTICS Holding AG from May 2022 to January 2024. Kelli's experience includes serving as a Regional Account Manager at Alexion from November 2014 to May 2022, an Area Business Specialist at NPS Pharma from January 2013 to November 2014, and a Clinical Science Associate / Regional Trainer at Genzyme Corporation from January 2001 to January 2013. Earlier in Kelli's career, positions included Senior Sales Representative and Senior Field Trainer at Roxane Laboratories / Boehringer Ingelheim from January 1998 to January 2001. Kelli holds a Bachelor of Science degree in Industrial Engineering and Chemical Engineering from the University of Massachusetts.